Neonatal myasthenia gravis is a rare temporary condition where newborns experience muscle weakness and difficulty feeding due to antibodies transferred from the mother. It is caused by maternal autoimmune antibodies against acetylcholine receptors that cross the placenta and interfere with nerve-muscle communication in the baby. The Myasthenia Gravis Panel 3 is the most important test for diagnosis because it detects the specific antibodies responsible for the condition.
90-day money-back guarantee
Lab order in minutes
Save a trip to the doctor
Low prices since 2005
Labs within 2 miles
Neonatal myasthenia gravis is caused by maternal autoimmune antibodies that cross the placenta during pregnancy and attack the baby's acetylcholine receptors. These antibodies, specifically anti-acetylcholine receptor antibodies and anti-MuSK antibodies, are produced by mothers who have myasthenia gravis and interfere with the communication between nerves and muscles in the newborn. The condition is temporary because the maternal antibodies naturally decline in the baby's bloodstream over the first few weeks to months of life as the infant's immune system matures and clears these transferred antibodies.
The Myasthenia Gravis Panel 3 is the most important test for neonatal myasthenia gravis because it detects the specific antibodies responsible for the condition, including anti-acetylcholine receptor antibodies and anti-MuSK antibodies. This comprehensive panel confirms the presence of maternal antibodies in the newborn's blood and helps distinguish neonatal myasthenia gravis from other causes of newborn muscle weakness like congenital myasthenic syndromes or metabolic disorders. Testing both the baby and the mother helps confirm the diagnosis and correlates antibody levels with symptom severity, which guides treatment decisions and monitoring as the condition resolves naturally over time.
You should get tested if your newborn shows signs of muscle weakness within the first few days of life, especially if you have been diagnosed with myasthenia gravis during pregnancy. Testing is essential if your baby has difficulty feeding, weak crying, poor muscle tone, drooping eyelids, or breathing problems. Immediate testing is critical because neonatal myasthenia gravis requires prompt medical attention to ensure proper feeding and breathing support while the maternal antibodies clear from the baby's system, and early diagnosis helps healthcare providers distinguish it from other serious conditions causing newborn weakness.
Save a trip to the doctor, go directly to the lab
Instant orders, results often overnight*
Results explained in simple language
Reviewed by US licensed doctors
Fast & confidential, we never sell or share your data
No insurance needed, transparent pricing
What this means
Your test detected acetylcholine receptor binding antibodies, which confirms a diagnosis of Myasthenia Gravis. These antibodies interfere with nerve-muscle communication, explaining symptoms like muscle weakness, fatigue, and difficulty with activities that worsen throughout the day.
Recommended actions
Consult with a neurologist to discuss treatment options including cholinesterase inhibitors or immunosuppressive therapy
Consider imaging studies to check for thymoma, especially given the positive striated muscle antibody correlation
Pace your daily activities with frequent rest breaks to prevent muscle exhaustion
Work with your healthcare team to monitor antibody levels and adjust treatment as needed
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
3303 reviews
Sample results
Your 24/7 Personal Lab Guide
Quick questions:
